tiprankstipranks
Carisma Therapeutics Board Changes and New Compensation Plans
Company Announcements

Carisma Therapeutics Board Changes and New Compensation Plans

Don't Miss Our Christmas Offers:

Carisma Therapeutics (CARM) just unveiled an announcement.

Regina Hodits and Björn Odlander are stepping down from the board of Carisma Therapeutics Inc. due to other commitments, with no disagreements cited. They will be replaced by Marella Thorell, who will chair the audit committee, and Dr. David Scadden, who will chair the science committee, both serving until the 2026 annual meeting. They will receive a $40,000 annual cash compensation plus additional fees and stock options, and enter into the company’s standard indemnification agreement. No related party transactions involving the new directors have been disclosed.

See more data about CARM stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyCarisma Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
TheFlyCarisma investors should ‘stay the course,’ says D. Boral Capital
TheFlyCarisma Therapeutics downgraded to Neutral from Outperform at Baird
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App